Evaluation of serum CA 125 levels in the monitoring of ovarian cancer
- 1 July 1987
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 157 (1), 88-92
- https://doi.org/10.1016/s0002-9378(87)80352-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancyCancer, 1986
- CA 125 surveillance and second-look laparotomy in ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Die klinische Bedeutung des Tumormarkers CA-125 für die präoperative Diagnostik und die postoperative Nachbetreuung von Patientinnen mit malignen OvarialtumorenGeburtshilfe und Frauenheilkunde, 1985
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- Erfahrungen mit CA 125, einem Tumormarker für maligne epitheliale Ovarialtumoren*Geburtshilfe und Frauenheilkunde, 1985
- Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour markerBritish Journal of Cancer, 1984
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerThe New England Journal of Medicine, 1983
- Reporting results of cancer treatmentCancer, 1981